Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Klein

Showing results (141-150 of 2,420) with videos related to

Pageof 242
Sort By:
Harefuah|October 1, 1987
[The third component of complement (C3) and its contribution to the immune response]E Yefenof, E Klein
Cancer Immunology, Immunotherapy : CII|January 1, 1982
Human T-cell cultures with selective autotumor reactivityF Vánky, E Klein
Seminars in Cancer Biology|February 1, 1991
Requirement of MHC class I antigen expression on human tumors for in vitro recognition by autologous blood lymphocytesF Vánky, E Klein
Nature|September 28, 2001
Bridge or ravine?G Klein, E Klein
Cancer Research|July 1, 1986
Conditioned tumorigenicity of activated oncogenesG Klein, E Klein
Transplantation|March 1, 1970
A microassay for cell-mediated immunityM Takasugi, E Klein
Advances in Cancer Research|January 1, 1992
Cancer immunotherapy: are the results discouraging? Can they be improved?E Kedar, E Klein
International Journal of Cancer|February 15, 1981
EBV infection of mitogen-stimulated human B lymphocytesL Einhorn, E Klein
Cytometry|July 1, 1984
Torbjörn Caspersson: some personal perspectivesG Klein, E Klein
International Journal of Cancer|May 15, 1982
Specificity of auto-tumor cytotoxicity exerted by fresh, activated and propagated human T lymphocytesF Vánky, E Klein
Pageof 242

Showing results (141-150 of 2,420) with videos related to

Sort By:
Pageof 242
Harefuah|October 1, 1987
[The third component of complement (C3) and its contribution to the immune response]E Yefenof, E Klein
Cancer Immunology, Immunotherapy : CII|January 1, 1982
Human T-cell cultures with selective autotumor reactivityF Vánky, E Klein
Seminars in Cancer Biology|February 1, 1991
Requirement of MHC class I antigen expression on human tumors for in vitro recognition by autologous blood lymphocytesF Vánky, E Klein
Nature|September 28, 2001
Bridge or ravine?G Klein, E Klein
Cancer Research|July 1, 1986
Conditioned tumorigenicity of activated oncogenesG Klein, E Klein
Transplantation|March 1, 1970
A microassay for cell-mediated immunityM Takasugi, E Klein
Advances in Cancer Research|January 1, 1992
Cancer immunotherapy: are the results discouraging? Can they be improved?E Kedar, E Klein
International Journal of Cancer|February 15, 1981
EBV infection of mitogen-stimulated human B lymphocytesL Einhorn, E Klein
Cytometry|July 1, 1984
Torbjörn Caspersson: some personal perspectivesG Klein, E Klein
International Journal of Cancer|May 15, 1982
Specificity of auto-tumor cytotoxicity exerted by fresh, activated and propagated human T lymphocytesF Vánky, E Klein
Pageof 242